CMG Pharmaceutical Co., Ltd. (KOSDAQ:058820)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,100.00
0.00 (0.00%)
Jul 18, 2025, 3:30 PM KST

CMG Pharmaceutical Revenue

CMG Pharmaceutical had revenue of 20.63B KRW in the quarter ending March 31, 2025, a decrease of -9.59%. This brings the company's revenue in the last twelve months to 96.91B, up 3.35% year-over-year. In the year 2024, CMG Pharmaceutical had annual revenue of 99.10B with 5.53% growth.

Revenue (ttm)
96.91B
Revenue Growth
+3.35%
P/S Ratio
3.19
Revenue / Employee
423.19M
Employees
229
Market Cap
309.16B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202499.10B5.19B5.53%
Dec 31, 202393.91B11.71B14.25%
Dec 31, 202282.20B23.57B40.21%
Dec 31, 201958.62B8.76B17.56%
Dec 31, 201849.86B8.33B20.05%
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Dec 31, 2013 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Samsung Biologics4,898.69B
Celltrion3,662.23B
ALTEOGEN151.65B
Yuhan2,114.76B
SK Biopharmaceuticals578.00B
HLB Co., Ltd.74.64B
Peptron4.30B
PharmaResearch392.31B
Revenue Rankings